Physician profile
Lauren Just
NPI 1548833478
$1,024.96
in general payments reported to CMS, 2019-2025
10 companies · $20.71 in 2025
The $20.71 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $174 · 2023: $135 · 2024: $696 · 2025: $20.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $851.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $402.75 | 2022-2024 | Gocovri, Gocovri |
| Teva Pharmaceuticals USA, INC. | $145.39 | 2022-2024 | Austedo Xr, Austedo |
| Abbvie INC. | $100.69 | 2023-2025 | |
| Kyowa Kirin, INC. | $94.87 | 2022-2024 | Nourianz |
| Pfizer INC. | $89.11 | 2024 | |
| Neurocrine Biosciences, INC. | $58.56 | 2022-2024 | Ingrezza |
| Biohaven Pharmaceutical Holding Company LTD. | $52.42 | 2022 | |
| Azurity Pharmaceuticals, INC. | $44.74 | 2024 | Horizant |
| Merz Pharmaceuticals, LLC | $18.63 | 2024 | Xeomin |
| Acadia Pharmaceuticals INC | $17.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Just listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.